NEOG · Nasdaq · CIK 0000711377

NEOGEN CORP

NEOGEN CORP’s most recent SEC filing in our snapshot is a Form 8-K/A filed on Oct 26, 2026. In fiscal 2026 (year ended May 31, 2026) it reported revenue of $870.4M and net income of -$7.9M, according to its XBRL data on EDGAR. Its EDGAR record lists 44 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2026
$870.4M
Net income, FY2026
-$7.9M
Form 4 filings on record, past 12 months
44

Company overview

Legal name (as filed)
NEOGEN CORP
Ticker
NEOG
SEC Central Index Key (CIK)
0000711377
Business address
LANSING, MI
State or country of incorporation
MI
Fiscal year ends
May 31
SEC filer category
Large accelerated filer
Position in SEC ticker list
#1799 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from NEOGEN CORP’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$527.2MFY2022$822.4MFY2023$924.2MFY2024$894.7MFY2025$870.4MFY2026
Net income
$48.3MFY2022-$22.9MFY2023-$9.4MFY2024-$1.1BFY2025-$7.9MFY2026
NEOG annual results
ItemFY2022
ended May 31, 2022		FY2023
ended May 31, 2023		FY2024
ended May 31, 2024		FY2025
ended May 31, 2025		FY2026
ended May 31, 2026
Revenue$527.2M$822.4M$924.2M$894.7M$870.4M
Net income$48.3M-$22.9M-$9.4M-$1.1B-$7.9M
Diluted EPS$0.45-$0.12-$0.04-$5.03-$0.04
Total assets$992.9M$4.6B$4.5B$3.4B$3.3B
Cash and equivalents$44.5M$163.2M$170.6M$129.0M$185.5M

XBRL tags used: revenue = RevenueFromContractWithCustomerExcludingAssessedTax; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

NEOG latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Jul 30, 202610-KAnnual report· period May 31, 2026Document · Index
Oct 7, 202610-QQuarterly report· period Aug 31, 2026Document · Index
Oct 7, 20268-KShareholder vote results· period Oct 1, 2026Document · Index
Aug 21, 2026DEF 14ADefinitive proxy statement· period Aug 21, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about NEOGEN CORP, by form type:

4 ×193 ×48-K ×4144 ×2S-8 ×2DEFA14A ×28-K/A ×110-Q ×1ARS ×1DEF 14A ×110-K ×1SCHEDULE 13G ×111-K ×1
NEOG recent filings
FiledFormWhat it isOriginal
Oct 26, 20268-K/ADirector or officer change· period Oct 1, 2026Document · Index
Oct 23, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 14, 2026Document · Index
Oct 23, 20263Initial statement of beneficial ownership· period Oct 1, 2026Document · Index
Oct 21, 20263Initial statement of beneficial ownership· period Oct 1, 2026Document · Index
Oct 21, 20263Initial statement of beneficial ownership· period Oct 1, 2026Document · Index
Oct 21, 20263Initial statement of beneficial ownership· period Oct 1, 2026Document · Index
Oct 20, 2026S-8Registration of employee benefit plan securitiesDocument · Index
Oct 20, 2026S-8Registration of employee benefit plan securitiesDocument · Index
Oct 9, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 9, 2026Document · Index
Oct 7, 202610-QQuarterly report· period Aug 31, 2026Document · Index
Oct 7, 20268-KShareholder vote results· period Oct 1, 2026Document · Index
Oct 6, 20268-KResults of operations· period Oct 6, 2026Document · Index
Oct 2, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 1, 2026Document · Index
Oct 2, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 1, 2026Document · Index
Oct 2, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 1, 2026Document · Index
Oct 2, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 1, 2026Document · Index
Oct 2, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 1, 2026Document · Index
Oct 2, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 1, 2026Document · Index
Oct 2, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 1, 2026Document · Index
Oct 2, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 1, 2026Document · Index
Sep 28, 2026DEFA14AAdditional proxy soliciting materialsDocument · Index
Aug 21, 2026ARSARS· period May 31, 2026Document · Index
Aug 21, 2026DEFA14AAdditional proxy soliciting materialsDocument · Index
Aug 21, 2026DEF 14ADefinitive proxy statement· period Aug 21, 2026Document · Index
Aug 20, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 19, 2026Document · Index
Aug 20, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 19, 2026Document · Index
Aug 14, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 14, 2026Document · Index
Aug 14, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 14, 2026Document · Index
Aug 14, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 14, 2026Document · Index
Aug 14, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 14, 2026Document · Index
Aug 14, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 14, 2026Document · Index
Aug 7, 20268-KDirector or officer change· period Aug 3, 2026Document · Index
Aug 6, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 4, 2026Document · Index
Jul 30, 202610-KAnnual report· period May 31, 2026Document · Index
Jul 30, 20268-KResults of operations· period Jul 30, 2026Document · Index
Jul 7, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Jun 25, 202611-KAnnual report of employee stock plans· period Dec 31, 2025Document · Index
Jun 4, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 3, 2026Document · Index
Jun 3, 2026144Notice of proposed sale of securitiesDocument · Index
May 29, 2026144Notice of proposed sale of securitiesDocument · Index

Insider filing activity

44 Form 4 filings appear in NEOGEN CORP’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in In Vitro & In Vivo Diagnostic Substances

All 8 companies in In Vitro & In Vivo Diagnostic Substances· Companies headquartered in Michigan

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0000711377 and XBRL company facts. NEOGEN CORP on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.